XML 44 R30.htm IDEA: XBRL DOCUMENT v3.7.0.1
Marketable Securities - Additional Information (Detail)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2017
USD ($)
Bond
Jun. 30, 2016
USD ($)
Jun. 30, 2017
USD ($)
Bond
Jun. 30, 2016
USD ($)
Dec. 31, 2016
USD ($)
Schedule Of Available For Sale Securities [Line Items]          
Available for sale securities remaining maturities greater than three years $ 0   $ 0   $ 0
Unrealized gains (losses) on available-for-sale securities, before tax (100,000) $ 200,000 (100,000) $ 1,200,000  
Unrealized gains (losses) available-for-sale securities, income tax expense 0 0 0 0  
Realized gains or losses available for sale securities     480,000    
Aggregate fair value of securities in an unrealized loss position for less than twelve months $ 127,200,000   127,200,000   102,500,000
Other-than-temporary impaired     $ 0   $ 0
Number of investment grade corporate bonds | Bond 45   45    
Audentes Therapeutics, Inc. [Member] | Common Equity Securities [Member] | Investment Income [Member]          
Schedule Of Available For Sale Securities [Line Items]          
Realized gains or losses available for sale securities $ 0 $ 0 $ 500,000 $ 0